Search Results for: crispr

Weekly reads: custom CRISPR therapy for baby, stem cells make amniotic sacs, 2 anti-aging influencer tweets, Nurown

CRISPR therapy, gene editing baby

There has been a sizable downturn for the CRISPR therapy biotech arena. Firms like Editas, Verve, Intellia, and even CRISPR Therapeutics, which has garnered an FDA approval, have had struggles recently. It feels like a disconnect here in a way because overall gene editing and gene therapy have never seemed more promising. But being a […]

Weekly reads: custom CRISPR therapy for baby, stem cells make amniotic sacs, 2 anti-aging influencer tweets, Nurown Read More »

Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s

HuidaGene Therapeutics, Chinese CRISPR biotech

Chinese CRISPR research continues to grow and this includes interesting CRISPR biotech firms. Some here in the U.S. worry that American gene editing firms could be lagging behind. Especially over the past year, investors and even some scientists have voiced frustration. U.S. gene editing firms like Editas have been struggling for years. Its stock is

Weekly reads: Chinese CRISPR biotechs, cultured meat war, MSCs for Alzheimer’s Read More »

Weekly reads: test-tube burgers, CRISPR for space travel, more tuft cells

test-tube burger

I’ve written before about so-called test-tube burgers and bacon and other lab grown meat. Test-tube burgers Cells like muscle and fat progenitor cells are the basis for these products. Sometimes stem cells may come into play for such “test-tube burgers” as I generally call this type of lab meat. Cost seems to be a main

Weekly reads: test-tube burgers, CRISPR for space travel, more tuft cells Read More »

Recommended reads: click editing, CRISPR v. progeria, diapause transcriptional program

click editing

Gene editing continues to advance both in the clinic trial arena and at more basic science levels including a report on a new approach called click editing. The two gene editing papers below highlight the variety of tools now available. Gene Editing papers including click editing Click editing enables programmable genome writing using DNA polymerases

Recommended reads: click editing, CRISPR v. progeria, diapause transcriptional program Read More »

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy

umbilical-cord-blood, umbilical cord blood stem cells

The private cord blood bank industry has promised families all kinds of great things over the years. A typical ad for such cord blood banks might say, “Your child may need cord blood in the future for a cure.” The industry also often uses the analogy of frozen cord blood as an insurance policy for

Recommended reads: private cord blood bank disappointments, Mammoth genomes, Huntington’s CRISPR, Parkinson’s cell therapy Read More »

Recommended reads: flesh-faced robots, ALS, Spina Bifida,neuronal CRISPR

flesh-faced robots

Combinations of human flesh and robots are more in the news lately. Sometimes the fleshy parts are grown from stem cells in a lab. Robots with fleshy faces Scientists in Japan Give Robots a Fleshy Face and a Smile, NYT. I’m working on a piece about robots in China with small, human brain-like structures. Stay tuned

Recommended reads: flesh-faced robots, ALS, Spina Bifida,neuronal CRISPR Read More »

Recommended reads: CAR-T for Lupus, CRISPR vision, journal closures

CAR-T for Lupus

Can researchers use CAR-T for lupus? It’s always exciting when one’s home institution has an interesting new therapy in development.  Here at UC Davis Health, there has been an increasing stream of such encouraging trials in the pipeline. I’ve written before about the promising trial of stem cells for spina bifida. Now there’s news related

Recommended reads: CAR-T for Lupus, CRISPR vision, journal closures Read More »

Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics

CRISPR Therapeutics

The biotechs Vertex and CRISPR Therapeutics have an interesting relationship as biotechs. They are partners are multiple levels but also are very different as companies including in size. There’s been a key development in one of their partnerships. Before we jump into that, please check out the video version of my 20 stem cell and

Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics Read More »

Weekly reads: new Sergiu Pasca pub, CRISPR chicken, human gene count update, stem cells in China

Sergiu Pasca, assembloid

Most of us have heard of organoids but what about the related model called an “assembloid”, which is a term growing in use including from organoid researcher Sergiu Pasca of Stanford? Before we jump into that, be sure to enter The Niche stem cell image contest for your chance to win $100 or some swag.

Weekly reads: new Sergiu Pasca pub, CRISPR chicken, human gene count update, stem cells in China Read More »